The story of Sildenafil presents a complex picture for investors. While the initial introduction generated substantial profits, the end of its patent opened the floodgates to off-brand versions, dramatically reducing https://lawsonwxdr200572.bloggerbags.com/47554707/sildenafil-and-the-pharmaceutical-industry-a-precarious-bet